World's Best Scientists 2026 revealed!
Allison L. Naleway

Allison L. Naleway

D-Index & Metrics

Microbiology

D-Index
69
Citations
17792
World Ranking
2033
National Ranking
859

Allison L. Naleway publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Allison L. Naleway sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 306 publications — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Allison L. Naleway D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Allison L. Naleway sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 69 D-Index — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Allison L. Naleway is affiliated with Kaiser Permanente in the United States and has made significant contributions primarily within the field of Medicine. The focus of their research includes multiple subfields such as Infectious Diseases, Epidemiology, Health, Obstetrics and Gynecology, and Public Health, Environmental and Occupational Health.

Their work covers a range of main topics including:

  • Vaccine Coverage and Hesitancy
  • SARS-CoV-2 and COVID-19 Research
  • Influenza Virus Research Studies
  • Respiratory Viral Infections Research
  • COVID-19 Clinical Research Studies
  • COVID-19 Impact on Reproduction
  • Viral Gastroenteritis Research and Epidemiology

Several notable papers by Allison L. Naleway include:

  • Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers - Eight U.S. Locations, December 2020-March 2021, 2021, MMWR Morbidity and Mortality Weekly Report
  • Surveillance for Adverse Events After COVID-19 mRNA Vaccination, 2021, JAMA
  • Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines, 2021, New England Journal of Medicine
  • Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings, 2021, New England Journal of Medicine
  • Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022, 2022, MMWR Morbidity and Mortality Weekly Report

Their frequent coauthors include:

  • Stephanie A. Irving
  • Nicola P. Klein
  • Manjusha Gaglani
  • Ousseny Zerbo
  • Malini B. DeSilva

Allison L. Naleway has published extensively in several key venues with the highest number of publications appearing in:

  • MMWR Morbidity and Mortality Weekly Report
  • Vaccine
  • Open Forum Infectious Diseases
  • Clinical Infectious Diseases
  • bioRxiv (Cold Spring Harbor Laboratory)

Best Publications

  • Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers - Eight U.S. Locations, December 2020-March 2021.

    Mark G. Thompson;Jefferey L. Burgess;Allison L. Naleway;Harmony L. Tyner

  • Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022

    Unknown

  • Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022

    Unknown

  • Surveillance for Adverse Events After COVID-19 mRNA Vaccination.

    Nicola P Klein;Ned Lewis;Kristin Goddard;Bruce Fireman

  • Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.

    Mark G Thompson;Jefferey L Burgess;Allison L Naleway;Harmony Tyner

  • Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings.

    Mark G Thompson;Edward Stenehjem;Shaun Grannis;Sarah W Ball

  • Measles-Mumps-Rubella-Varicella Combination Vaccine and the Risk of Febrile Seizures

    Nicola P. Klein;Bruce Fireman;W. Katherine Yih;Edwin Lewis

  • The Vaccine Safety Datalink: A Model for Monitoring Immunization Safety

    James Baggs;Julianne Gee;Edwin Lewis;Gabrielle Fowler

  • Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years — VISION Network, 10 States, April 2021–January 2022

    Unknown

  • Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the Vaccine Safety Datalink.

    Julianne Gee;Allison Naleway;Irene Shui;James Baggs

  • Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort, July 2021–February 2022

    Unknown

  • Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study

    Unknown

  • Risk of Intussusception after Monovalent Rotavirus Vaccination

    Eric S. Weintraub;James Baggs;Jonathan Duffy;Claudia Vellozzi

  • The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety

    Michael M. McNeil;Julianne Gee;Eric S. Weintraub;Edward A. Belongia

  • Evaluation of the Association of Maternal Pertussis Vaccination With Obstetric Events and Birth Outcomes

    Elyse O. Kharbanda;Gabriela Vazquez-Benitez;Heather S. Lipkind;Nicola P. Klein

  • Evaluation of the Association of Maternal Pertussis Vaccination With Obstetric Events and Birth Outcomes

    Elyse O. Kharbanda;Gabriela Vazquez-Benitez;Heather S. Lipkind;Nicola P. Klein

  • Smallpox Vaccine: The Good, the Bad, and the Ugly

    Edward A. Belongia;Allison L. Naleway

  • Asthma and farm exposures in a cohort of rural Iowa children.

    James A. Merchant;Allison L. Naleway;Erik R. Svendsen;Kevin M. Kelly

  • Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated — VISION Network, 10 States, December 2021–June 2022

    Unknown

  • Spontaneous Abortion Following COVID-19 Vaccination During Pregnancy.

    Elyse O Kharbanda;Jacob Haapala;Malini DeSilva;Gabriela Vazquez-Benitez

  • Effectiveness of Seasonal Trivalent Influenza Vaccine for Preventing Influenza Virus Illness Among Pregnant Women: A Population-Based Case-Control Study During the 2010–2011 and 2011–2012 Influenza Seasons

    Mark G. Thompson;De-Kun Li;Pat Shifflett;Leslie Z. Sokolow;Leslie Z. Sokolow

  • Delivering Influenza Vaccine to Pregnant Women

    Allison L. Naleway;Wendy J. Smith;John P. Mullooly

  • Influenza Vaccine Effectiveness in Preventing Influenza-associated Hospitalizations During Pregnancy: A Multi-country Retrospective Test Negative Design Study, 2010-2016

    Mark G Thompson;Jeffrey C Kwong;Annette K Regan;Annette K Regan;Mark A Katz;Mark A Katz;Mark A Katz

  • COVID-19 Vaccination Coverage Among Pregnant Women During Pregnancy - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 8, 2021.

    Hilda Razzaghi;Mehreen Meghani;Cassandra Pingali;Bradley Crane

  • A population-based cohort study of undervaccination in 8 managed care organizations across the United States.

    Jason M. Glanz;Sophia R. Newcomer;Komal J. Narwaney;Simon J. Hambidge

  • Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults - Nine States, January-September 2021.

    Peter J Embi;Matthew E Levy;Allison L Naleway;Palak Patel

  • Prevention and Attenuation of COVID-19 by BNT162b2 and mRNA-1273 Vaccines

    Mark G Thompson;Jefferey L Burgess;Allison Naleway;Harmony Tyner

Frequent Co-Authors

Nicola P. Klein
Nicola P. Klein Kaiser Permanente
Mark G. Thompson
Mark G. Thompson Centers for Disease Control and Prevention
Lisa A. Jackson
Lisa A. Jackson Kaiser Permanente
Edward A. Belongia
Edward A. Belongia Marshfield Clinic
Roger Baxter
Roger Baxter Kaiser Permanente
Manjusha Gaglani
Manjusha Gaglani Baylor College of Medicine
Grace M. Lee
Grace M. Lee Stanford University
Steven J. Jacobsen
Steven J. Jacobsen Kaiser Permanente
Frank DeStefano
Frank DeStefano Centers for Disease Control and Prevention
Bruce Fireman
Bruce Fireman Kaiser Permanente

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in microbiology, exploring related online degrees can open diverse career opportunities in healthcare and research. Many students consider programs like an accelerated medical billing and coding certificate online to quickly enter the medical administration field, complementing scientific knowledge with essential healthcare management skills.

Additionally, pursuing various online healthcare degrees that pay well can lead to rewarding jobs that leverage a microbiology background, such as clinical research or public health. For those aiming at public health, identifying the best easiest mph online programs to get into offers flexibility and faster access to advanced roles in epidemiology and health policy.

Moreover, careers like child life specialist blend science with patient care, focusing on the emotional well-being of children in healthcare settings. Learning about child life specialist salary can help gauge the financial prospects of such specialized paths linked to microbiology.

Overall, selecting related online degrees can enhance career versatility, helping microbiology graduates build specialized skills and find meaningful, well-compensated roles in the healthcare landscape.

Best Scientists Citing Allison L. Naleway

Trending Scientists